Comparison

Lagociclovir European Partner

Item no. TMO-T15704-10mM
Manufacturer TargetMol
CASRN 92562-88-4
Amount 1 mL x 10 mM (in DMSO)
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles O=C1C2=C(N(C=N2)[C@@H]3O[C@H](CO)[C@@H](F)C3)NC(N)=N1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias MIV-210
Shipping Condition Cool pack
Available
Manufacturer - Targets
HBV
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
269.23
Description
Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.
Pathways
Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL x 10 mM (in DMSO)
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close